Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer

BACKGROUND: Trifluridine/tipiracil (TAS-102, Lonsurf®), a novel oral anti-tumor agent combining an anti-neoplastic thymidine-based nucleoside analogue (trifluridine, FTD) with a thymidine phosphorylase inhibitor (tipiracil hydrochloride, TPI) presents a new treatment option for metastatic colorectal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasper, Stefan, Kisro, Jens, Fuchs, Martin, Müller, Christian, Schulz-Abelius, Armin, Karthaus, Meinolf, Rafiyan, Mohammad-Reza, Stein, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240219/
https://www.ncbi.nlm.nih.gov/pubmed/30445951
http://dx.doi.org/10.1186/s12885-018-5063-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240219/
https://www.ncbi.nlm.nih.gov/pubmed/30445951
http://dx.doi.org/10.1186/s12885-018-5063-5

Ejemplares similares